Arthur Tzianabos - 13 Feb 2024 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role: Director
Signature: /s/ Stephen Tulipano, Attorney-in-Fact
Issuer symbol: STOK
Transactions as of: 13 Feb 2024
Net transactions value: +$69,508
Form type: 4
Filing time: 15 Feb 2024, 16:17:45 UTC
Previous filing: 15 Feb 2024
Next filing: 27 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	STOK	Common Stock	Options Exercise	$69,508	+31,739		$2.19	31,739	13 Feb 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	STOK	Stock Option (Right to Buy)	Options Exercise	$0	-31,739	-100%	$0.000000^*	0	13 Feb 2024	Common Stock	31,739	$2.19	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This fully-vested option award vested as to 1/48th of the total award on October 4, 2018 with 1/48th of the total award vesting monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.